ARTICLE | Company News
AstraZeneca cancer, pharmacogenetics news
June 5, 2006 7:00 AM UTC
AZN will invest $100 million over three years to form the AstraZeneca Innovation Center in China. The center will research biomarkers in Chinese patients and will initially focus on cancer. ...